Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 3/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.43 |
| ▸ | ORAI1 | Q96D31 | 2/20 | 0.43 |
| ▸ | ORAI2 | Q96SN7 | 2/20 | 0.43 |
| ▸ | ORAI3 | Q9BRQ5 | 2/20 | 0.43 |
| ▸ | TRPV6 | Q9H1D0 | 2/20 | 0.43 |
| ▸ | CA6 | P23280 | 1/20 | 0.43 |
| ▸ | CA5A | P35218 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.43 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.43 |
| ▸ | PCSK9 | Q8NBP7 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 6/20 | 0.36 |
| ▸ | CA2 | P00918 | 6/20 | 0.36 |
| ▸ | MGLL | Q99685 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | CA3 | P07451 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL117185 | 0.87 | TDP1 (0.37) | CA4CA14ORAI1ORAI2ORAI3 | |
| Hydrochloric Acid SCHEMBL411461 | 0.79 | — | — | |
| Bromide SCHEMBL1985235 | 0.79 | — | — | |
| Water SCHEMBL2808996 | 0.79 | — | — | |
| Iodide SCHEMBL9805251 | 0.79 | — | — | |
| Bromide SCHEMBL11879388 | 0.76 | TDP1 (0.39) | CA4CA14CA7CA1CA2 | |
| Phenol SCHEMBL31536802 | 0.75 | CA4 (0.43) | CA4CA14ORAI1ORAI2ORAI3 | |
| Bicarbonate SCHEMBL2810754 | 0.75 | CA2 (0.50) | CA4CA14CA6CA5ACA7 | |
| SCHEMBL11439905 | 0.73 | — | — | |
| SCHEMBL10594453 | 0.73 | CA4 (0.36) | CA4CA14CA6CA5ACA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12640053-B2 | GYN pathology surgical simulation models and systems for surgical training | APPLIED MEDICAL RESOURCES CORPORATION (US) | 2026-05-26 | — | — | US | disclosed |
| US-20260124286-A1 | E. COLI FIMH MUTANTS AND USES THEREOF | PFIZER INC. (US) | 2026-05-07 | — | — | US | disclosed |
| US-12611201-B2 | Absorptive tip brush biopsy device, kit and method | TECHMED VENTURES LLC (US) | 2026-04-28 | — | — | US | disclosed |
| EP-4728076-A1 | METHOD FOR STABILIZING RNA | Pfizer Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| US-20260102147-A1 | BRUSH BIOPSY DEVICE, KIT AND METHOD | TECHMED VENTURES LLC (US) | 2026-04-16 | — | — | US | disclosed |
| US-20260077104-A1 | Bioelectric Thread and Delivery Device | UNIV BROWN (US) | 2026-03-19 | — | — | US | disclosed |
| EP-3515571-B1 | ISOTOPIC COMPOSITIONS | BOTANICAL WATER TECH IP LTD (GB) | 2026-01-07 | — | — | EP | disclosed |
| US-12508279-B2 | Compositions and methods for enhancing innate immunity in a subject for treatment of infections and cancer and other acute and chronic conditions of the eye | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2025-12-30 | — | — | US | disclosed |
| WO-2025264674-A1 | COMPOSITION FOR PERSONAL CARE PRODUCTS | VAGINAL BIOME SCIENCE, INC. (US) | 2025-12-26 | — | — | WO | disclosed |
| US-20250381121-A1 | COMPOSITION FOR PERSONAL CARE PRODUCTS | VAGINAL BIOME SCIENCE INC (US) | 2025-12-18 | — | — | US | disclosed |
| CN-110312492-B | Artificial airway management apparatus, systems and methods | 因多克里公司 | 2022-04-08 | — | — | CN | disclosed |
| US-20220087805-A1 | Urinary Plug Device | HESSE DAVID (US) | 2022-03-24 | — | — | US | disclosed |
| WO-2022056038-A1 | ABSORPTIVE TIP BRUSH BIOPSY DEVICE, KIT AND METHOD | TECHMED VENTURES, LLC (US) | 2022-03-17 | — | — | WO | disclosed |
| US-11246693-B2 | Urinary plug device | HESSE DAVID (US) | 2022-02-15 | — | — | US | disclosed |
| US-9932300-B2 | N,N′-diarylurea compounds and N,N′-diarylthiourea compounds as inhibitors of translation initiation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2018-04-03 | — | — | US | disclosed |
| US-20160318857-A1 | N,N'-Diarylurea Compounds and N,N'-Diarylthiourea Compounds as Inhibitors of Translation Initiation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2016-11-03 | — | — | US | disclosed |
| US-9421211-B2 | N,N′-diarylurea compounds and N,N′-diarylthiourea compounds as inhibitors of translation initiation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2016-08-23 | — | — | US | disclosed |
| US-20120115915-A1 | N,N'-DIARYLUREA COMPOUNDS AND N,N'-DIARYLTHIOUREA COMPOUNDS AS INHIBITORS OF TRANSLATION INITIATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2012-05-10 | — | — | US | disclosed |
| US-7927613-B2 | Pharmaceutical co-crystal compositions | UNIVERSITY OF SOUTH FLORIDA (US) | 2011-04-19 | — | — | US | disclosed |
| US-7790905-B2 | Pharmaceutical propylene glycol solvate compositions | MCNEIL-PPC, INC. (US) | 2010-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12508279-B2 | Compositions and methods for enhancing innate immunity in a subject for treatment of infections and cancer and other acute and chronic conditions of the eye | TLR9, TLR3, TLR6 | CA4 3565/4885CA14 2730/4885ORAI1 636/4885 |
| US-20160318857-A1 | N,N'-Diarylurea Compounds and N,N'-Diarylthiourea Compounds as Inhibitors of Translation Initiation | NSUN2, EIF2AK2, RNGTT | CA4 4749/4885CA14 4405/4885ORAI1 3761/4885 |
| US-12640053-B2 | GYN pathology surgical simulation models and systems for surgical training | CDH1, EPCAM, ZP1 | CA4 4398/4885CA14 2280/4885ORAI1 1127/4885 |
| US-20260102147-A1 | BRUSH BIOPSY DEVICE, KIT AND METHOD | KRT18, PAX2, SETDB1 | CA4 2120/4885CA14 481/4885ORAI1 483/4885 |
| US-20260077104-A1 | Bioelectric Thread and Delivery Device | TNNI3, TNNT2, TTN | CA4 4350/4885CA14 4216/4885ORAI1 1128/4885 |
| US-20260124286-A1 | E. COLI FIMH MUTANTS AND USES THEREOF | Q6ZSR9, MRPL21, F13A1 | CA4 3786/4885CA14 2219/4885ORAI1 1993/4885 |
| US-12611201-B2 | Absorptive tip brush biopsy device, kit and method | PAX8, PAX2, KRT18 | CA4 1699/4885CA14 527/4885ORAI1 1370/4885 |
| US-20120115915-A1 | N,N'-DIARYLUREA COMPOUNDS AND N,N'-DIARYLTHIOUREA COMPOUNDS AS INHIBITORS OF TRANSLATION INITIATION | NSUN2, EIF2AK2, RNGTT | CA4 4749/4885CA14 4405/4885ORAI1 3761/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.